MODEL OF HLA-INCOMPATIBLE HUMANIZED NSG MOUSE WITH XENOGRAFT OBTAINED FROM A PATIENT Russian patent published in 2021 - IPC A01K67/27 C07K14/55 C07K14/705 C12N15/85 G01N33/50 

Abstract RU 2757421 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, in particular to a humanized immunodeficient non-obese with diabetic (NOD) mouse as a model, as well as to a method for its creation. The use of the above-mentioned mouse is also disclosed in a method for predicting the ranking of the effectiveness of a variety of antitumor remedies for the treatment of a tumor, a method for testing a combination therapy for the treatment of a tumor using two or more candidate remedies, a method for determining the efficiency of a dosage regimen for the treatment of a tumor using a remedy, as well as in a method for determining the safety of a dosage regimen for the treatment of a tumor using a remedy.

EFFECT: invention makes it possible to effectively study human-specific infections and treatment methods, which, thus, provides clinically significant in vivo studies of human cells, tissues and immune systems without risk to patients.

19 cl, 16 dwg, 2 tbl, 9 ex

Similar patents RU2757421C2

Title Year Author Number
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR APPLICATION 2013
  • Flavell Richard A.
  • Mants Markus
  • Ronvo Entoni
  • Strovig Til
  • Villindzher Tim
  • Merfi Endryu Dzh.
  • Stivens Shon
  • Yankopulos Dzhordzh
RU2642319C2
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR USE 2013
  • Flavell, Richard, A.
  • Manz, Markus
  • Rongvaux, Anthony
  • Strowig, Till
  • Willinger, Tim
  • Murphy, Andrew J.
  • Stevens, Sean
  • Yancopoulos, George
RU2768282C2
GENETICALLY MODIFIED ANIMALS NOT RELATED TO HUMAN RACE AND THEIR APPLICATION METHODS 2013
  • Flavell, Richard
  • Strowig, Till
  • Manz, Markus G.
  • Borsotti, Chiara
  • Dhodapkar, Madhav
  • Murphy, Andrew J.
  • Stevens, Sean
  • Yancopoulos, George D.
RU2775425C2
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS FOR USE THEREOF 2013
  • Flavell Richard
  • Strovig Til
  • Mants Markus G.
  • Borsotti Kyara
  • Dkhodapkar Madkhav
  • Merfi Endryu Dzh.
  • Stivens Shon
  • Yankopulos Dzhordzh D.
RU2673156C2
GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO 2015
  • Merfi, Endryu Dzh.
  • Stivens, Shon
  • Flavell, Richard
  • Mants, Markus
  • Shan, Lyan
RU2799086C2
APPLICATION OF PROPAGATED POPULATIONS OF HEMATOPOIETIC STEM CELLS/PROGENITOR CELLS 2016
  • Delaney, Colleen
RU2747728C2
ANTI-CANCER TARGETED IMMUNOTHERAPY WITH APPLICATION OF IL-12 2015
  • Shrittmatter Volfgang
  • Khandgretinger Rupert
  • Shilbakh-Shtyukle Karin
RU2689160C2
NON-HUMAN GENETICALLY MODIFIED ANIMALS EXPRESSING HUMAN EPO 2015
  • Murphy, Andrew J.
  • Stevens, Sean
  • Flavell, Richard
  • Manz, Markus
  • Shan, Liang
RU2711744C1
METHOD OF CELL EXPANSION, METHOD OF OBTAINING CONDITIONED MEDIUM, POPULATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE, PHARMACEUTICAL COMPOSITION AND APPLICATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE IN TRANSPLANTATION 2007
  • Meretski Shaj
  • Aberman Zami
  • Bjurger Ora
RU2433177C2
METHOD FOR EVALUATING EFFICACY OF RADIOPROTECTIVE DRUGS USING HUMANISED MICE 2023
  • Atamanyuk Natalya Igorevna
  • Pryakhin Evgenij Aleksandrovich
  • Styazhkina Elena Vladimirovna
  • Obvintseva Nadezhda Aleksandrovna
  • Andreev Sergej Sergeevich
  • Peretykin Andrej Anatolevich
  • Tryapitsyna Galina Aleksandrovna
  • Akleev Aleksandr Vasilevich
RU2817986C1

RU 2 757 421 C2

Authors

Keck, James

Dates

2021-10-15Published

2016-06-22Filed